Compounds and methods targeting interleukin-34
Номер патента: EP4423128A1
Опубликовано: 04-09-2024
Автор(ы): Adam S. Fleisher, Albert Lo, Andrew Dixon Skora, Elizabeth Anne West, John Randall II SIMS, Marcio Chedid, Mark Mintun, Megan Brittany Lannan, Ming Ye, Robin Elizabeth Walsh, Sarah Elisabeth Raines, Victor H. Obungu
Принадлежит: Eli Lilly and Co
Опубликовано: 04-09-2024
Автор(ы): Adam S. Fleisher, Albert Lo, Andrew Dixon Skora, Elizabeth Anne West, John Randall II SIMS, Marcio Chedid, Mark Mintun, Megan Brittany Lannan, Ming Ye, Robin Elizabeth Walsh, Sarah Elisabeth Raines, Victor H. Obungu
Принадлежит: Eli Lilly and Co
Реферат: The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease.
Compounds and methods targeting interleukin-34
Номер патента: AU2022376930A1. Автор: Ming Ye,Albert Lo,Marcio Chedid,Mark Mintun,John Randall II SIMS,Andrew Dixon Skora,Victor H. Obungu,Adam S. Fleisher,Megan Brittany Lannan,Sarah Elisabeth Raines,Robin Elizabeth Walsh,Elizabeth Anne West. Владелец: Eli Lilly and Co. Дата публикации: 2024-05-02.